AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2011
Aug 5, 2011
32939_dirs_2011-08-05_30e77737-1ef9-4f3b-9e96-eb31c91789cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2011-08-03
Reporting Person: Solano Scott J. (Interim CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-03 | Common Stock | A | 6000 | — | Acquired | 6000 | Direct |
| 2011-08-03 | Common Stock | A | 4617 | — | Acquired | 10617 | Direct |
| 2011-08-03 | Common Stock | F | 1672 | $13.53 | Disposed | 8945 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-08-03 | Non-Qualified Stock Option (right to buy) | $13.53 | A | 10500 | Acquired | 2018-08-03 | Common Stock (10500) | Direct |
Footnotes
F1: The acquisition of 6,000 shares of common stock is a restricted stock unit representing a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 8/3/2012.
F2: The exempt disposition of 1,672 shares was made to satisfy tax withholding obligations.
F3: Options for 25% of the shares are each exercisable on 8/3/2012, 8/3/2013, 8/3/2014 and 8/3/2015, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Board/Management Information
2026
Feb 3
Investor Presentation
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Earnings Release
2026
Jan 6